Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.
Start 7-day free trial → Log in

SPR741 · NAB-741

Other · developed by Spero Therapeutics

Phase 1 Most advanced trial (none active)
SPRO Developer
1 Registered trials

What is SPR741?

SPR741 is an investigational drug studied in Healthy Volunteers.

At a glance

Also known as
NAB-741
Drug type
Other
Developer
Spero Therapeutics (SPRO)
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 1
UNII
XQ4XZ5Y4KE

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT03376529 Phase 1 Healthy Volunteers Completed SPRO

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Healthy Volunteers

More from Spero Therapeutics

SPR206 Phase 1 SPR720 Phase 2

Follow SPRO, the company behind SPR741

See SPRO's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

SPRO catalysts and pipeline →
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.